CRABP2 is highly expressed in poorly differentiated liver cancer, knocking down CRABP2 can inhibit the proliferation, migration, and invasion of liver cancer cell lines, promote cell apoptosis, and reduce the expression of ERK/VEGF pathway-related proteins. The gene discussed is VEGFA; the disease is liver cancer.